To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE RAISES ATTRIBUTABLE NET PROFIT 78% (AMENDMENT)

Release Date: 22/08/2001 15:01
Code(s): APN
Wrap Text
Share Code: APN
ISIN Code: ZAE000023586

With reference to the press announcement released today at 12:29, please note the change in the second paragraph, fourth point. It should read : Press Release
Aspen Pharmacare, Southern Africa's largest generics manufacturer and the largest JSE-listed pharmaceutical company, has announced an outstanding performance for the financial year ended June 2001.
* Turnover from continuing operations increased by 18 percent to R1.118 billion (R0.95 billion).
* Headline earnings per share (HEPS) rose 43 percent to 48.4 cents (33.8 cents). After excluding discontinued operations the increase in HEPS amounted to 81 percent.
* Operating profit from continuing operations before amortisation rose 41 percent from R212.4M to R298.5M.
* Net profit attributable to ordinary shareholders increased 78% to R178,9M (R100.7M).

Share This Story